Retrospective Study
Copyright ©The Author(s) 2023.
World J Gastrointest Surg. Nov 27, 2023; 15(11): 2463-2469
Published online Nov 27, 2023. doi: 10.4240/wjgs.v15.i11.2463
Table 2 The relationship between the expression of metastasis-associated factor-1, vacuolar ATP synthase and clinicopathological features of colon cancer
Clinicopathologcal features
Cases
MACC1 positive expression (%)
χ2
P value
V-ATPase positive expression (%)
χ2
P value
Age (years)
    ≤ 55 years old5433 (61.11)0.5380.46335 (64.81)0.3170.573
    > 55 years old5034 (68.00)35 (70.00)
Gender
    Male5635 (62.50)0.1960.65840 (71.43)0.9360.333
    Female4832 (66.67)30 (62.50)
Tumor site
    Left colon5032 (64.00)0.0080.93136 (72.00)0.9640.326
    Right colon5435 (64.81)34 (62.96)
TNM staging
    Phase Ⅰ-Ⅱ6534 (52.31)11.1010.00135 (53.85)14.2750.000
    Phase Ⅲ3933 (84.62)35 (89.74)
Degree of differentiation
    High differentiation3112 (38.71)12.740.00011 (35.48)20.3270.000
    Medium and low differentiation7355 (75.34)59 (80.82)
Lymph node metastasis
    Yes4940 (81.63)11.9730.00142 (85.71)14.2660.000
    No5527 (49.09)28 (50.91)
Vascular infiltration
    Yes4124 (58.54)1.0230.31226 (63.41)0.4660.496
    No6343 (68.25)44 (69.84)
Nervous system infiltration
    Yes3222 (68.75)0.3780.53921 (65.63)0.0590.807
    No7245 (62.50)49 (68.06)
Tumor diameter
    > 5 cm6046 (76.67)9.2760.00240 (66.67)0.0260.871
    ≤ 5 cm4421 (47.73)30 (68.18)